Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:06 PM
Ignite Modification Date:
2025-12-24 @ 9:06 PM
NCT ID:
NCT02089204
Eligibility Criteria:
Inclusion Criteria:
* histologically confirmed NPC by biopsy,
* no evidence of distant metastasis,
* no previous treatment for NPC,
* Stages III\~IVA (AJCC 7th Edition) of locally advanced ,
* adequate liver function (albumin ≥30 g/L),
* adequate renal function (creatinine ≤100μmol/L) ,
* adequate bone marrow function(white blood count ≥ 4.0×109/L, platelets ≥ 100×109/L),
* Karnofsky performance status≥70,
Exclusion Criteria:
* Patients younger than 18,
* those with a prior (within 5 years) or synchronous malignancy were excluded.
* presence of distant metastases,
* pregnancy or lactation,
* other concomitant malignant disease.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT02089204
Study Brief:
Protocol Section:
NCT02089204